| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |